Al­ler­gan on the hook for $160M for hy­dro­cor­ti­sone ‘abuse of dom­i­nance,’ UK court rules

A UK com­pe­ti­tion tri­bunal has up­held fines worth hun­dreds of mil­lions of pounds against Al­ler­gan in a broad­er probe in­to its af­fil­i­ates for over­charg­ing the Na­tion­al Health Ser­vice (NHS) for hy­dro­cor­ti­sone tablets.

The UK’s Com­pe­ti­tion and Mar­kets Au­thor­i­ty (CMA) pro­posed a fine of £155.2 mil­lion ($192.4 mil­lion) for Al­ler­gan’s abuse of dom­i­nance, but the tri­bunal shaved off around £26 mil­lion ($32.2 mil­lion). This was be­cause Al­ler­gan — for­mer par­ent of Ac­tavis UK — couldn’t be held re­spon­si­ble for Ac­tavis due to “hold sep­a­rate” com­mit­ments.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.


Alexandria Real Estate Equities

Cambridge, MA, USA